BIOMAT Database Logo BIOMAT Database Logo

Serum insulin, pancreatic glucagon and growth hormone levels in response to intravenous infusion of L-arginine in patients with recently detected juvenile diabetes. 1976

J Lawecki, and A Symonides-Lawecka, and H Rogala

The secretion of insulin, glucagon and growth hormone was determined in the serum of patients with recently diagnosed juvenile-type diabetes (10 patients) during stimulation by intravenous infusion of L-arginine and was compared with the results found in a group of five healthy persons. The value of the insulinemia was significantly lower in the diabetics as compared with the healthy controls. Serum glucagon levels were higher in all diabetics when fasting and after L-arginine administration as compared with the controls but a significant difference was observed only at the peck of secretion (5 min after L-arginine administration). Growth hormone concentration was slightly higher in the diabetics after secretory stimulation than in the controls, particularly at the peak of secretion (30 and 45 min) but the difference was statistically no significant.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

J Lawecki, and A Symonides-Lawecka, and H Rogala
Response of insulin, glucagon and growth hormone to arginine infusion in patients with chronic renal failure.
January 1979, Nephron,
J Lawecki, and A Symonides-Lawecka, and H Rogala
Serum insulin and growth hormone response to arginine infusion in healthy and psoriatic persons.
January 1973, Dermatologica,
J Lawecki, and A Symonides-Lawecka, and H Rogala
Insulin and glucagon response to arginine infusion in cystic fibrosis.
March 1977, Acta paediatrica Scandinavica,
J Lawecki, and A Symonides-Lawecka, and H Rogala
Blood glucose, serum insulin and growth hormone response to intravenous administration of arginine in premature infants.
January 1972, Biology of the neonate,
J Lawecki, and A Symonides-Lawecka, and H Rogala
[Plasma levels of growth hormone, insulin and glucose, during sequential intravenous administration of L-arginine and insulin].
January 1972, Archivos de investigacion medica,
J Lawecki, and A Symonides-Lawecka, and H Rogala
Serum insulin and growth hormone response patterns in monozygotic twin siblings of patients with juvenile-onset diabetes.
July 1975, The New England journal of medicine,
J Lawecki, and A Symonides-Lawecka, and H Rogala
[Endocrine pancreatic dysfunction in chronic pancreatitis, with special reference to glucagon and insulin secretion during intravenous infusion of arginine].
December 1976, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
J Lawecki, and A Symonides-Lawecka, and H Rogala
Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus.
July 1994, Clinical science (London, England : 1979),
J Lawecki, and A Symonides-Lawecka, and H Rogala
[Changes of insulin antagonists in juvenile diabetes mellitus--with special reference to growth hormone and glucagon].
September 1978, Horumon to rinsho. Clinical endocrinology,
J Lawecki, and A Symonides-Lawecka, and H Rogala
Plasma glucagon, insulin and glucose responses to intravenous arginine infusion in the rat.
March 1978, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Copied contents to your clipboard!